{"id": "1384861584724566028", "creation": 1619011705.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Bharat Biotech and ICMR AnnounceInterim Results from Phase 3 trials of COVAXIN\u00ae (#COVID19India #vaccine); Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe #COVID19 disease\nhttps://t.co/AhyCaExieQ https://t.co/g02KInCGsm", "first_save": 1634559108.199414, "hashtags": ["#COVID19INDIA", "#VACCINE", "#COVID19"]}